Literature DB >> 25405820

Genetics of vasculitis.

Francisco David Carmona1, Javier Martín, Miguel A González-Gay.   

Abstract

PURPOSE OF REVIEW: We aim to give an overview of the recent progress in the knowledge of the genetic component of vasculitides. RECENT
FINDINGS: Using a state-of-the-art imputation method to analyse the major histocompatibility complex (MHC) region, Ombrello and colleagues narrowed down the association between human leukocyte antigen (HLA)-B51 and Behçet's disease to a model of five amino acids of the HLA-B molecule involved in the binding of the antigen, the interactions with receptors on CD8 T cells and natural killer cells, and the signal peptide of HLA-B, suggesting a crucial role of the cellular cytotoxicity on this disease. Other recent genetic studies have identified several loci with strong effects on vasculitis predisposition, most of them representing important players in the immune and inflammatory response. These associations include ERAP1, CCR1-CCR3, STAT4, KLRC4, GIMAP4, and TNFAIP3 in Behçet's disease; BLK and CD40 in Kawasaki disease; SERPINA1 and SEMA6A in antineutrophil cytoplasmic antibody associated vasculitides; IL12B and FCGR2A/ FCGR2A in Takayasu arteritis; and CECR1 in a newly defined vascular inflammatory syndrome associated with adenosine deaminase (ADA2) deficiency. Although other vasculitides, such as giant cell arteritis (GCA) or immunoglobulin A vasculitis, have not benefitted by the great advantage of the large-scale genetic analyses yet, some interesting associations have been recently suggested, such as the classical functional PTPN22 allele rs2476601 (R620W) with GCA.
SUMMARY: The analysis of high-throughput genotyping and exome-sequencing data has produced a considerable advance in the identification of consistent genetic risk factors in vasculitides during the last 3 years. Further collaborative efforts, which will increase the sample size, and the use of custom arrays like the immunochip, will definitively help to better understand the genetic basis of vasculitides and to identify the common and specific molecular pathways underlying their pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25405820     DOI: 10.1097/BOR.0000000000000124

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  18 in total

Review 1.  An update on the role of epigenetics in systemic vasculitis.

Authors:  Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

Review 2.  Pulmonary vasculitis.

Authors:  Ana Casal; Juan Díaz-Garel; Tara Pereiro; María E Toubes; Jorge Ricoy; Luis Valdés
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 3.  Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.

Authors:  Thâmara Cristiane Alves Batista Morita; Gabriela Franco S Trés; Roberta Fachini Jardim Criado; Mirian Nacagami Sotto; Paulo Ricardo Criado
Journal:  An Bras Dermatol       Date:  2020-03-26       Impact factor: 1.896

Review 4.  Epigenetics and Vasculitis: a Comprehensive Review.

Authors:  Paul Renauer; Patrick Coit; Amr H Sawalha
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 5.  Diagnosis and differential diagnosis of large-vessel vasculitides.

Authors:  Gokhan Keser; Kenan Aksu
Journal:  Rheumatol Int       Date:  2018-09-17       Impact factor: 2.631

6.  A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Authors:  F David Carmona; Augusto Vaglio; Sarah L Mackie; José Hernández-Rodríguez; Paul A Monach; Santos Castañeda; Roser Solans; Inmaculada C Morado; Javier Narváez; Marc Ramentol-Sintas; Colin T Pease; Bhaskar Dasgupta; Richard Watts; Nader Khalidi; Carol A Langford; Steven Ytterberg; Luigi Boiardi; Lorenzo Beretta; Marcello Govoni; Giacomo Emmi; Francesco Bonatti; Marco A Cimmino; Torsten Witte; Thomas Neumann; Julia Holle; Verena Schönau; Laurent Sailler; Thomas Papo; Julien Haroche; Alfred Mahr; Luc Mouthon; Øyvind Molberg; Andreas P Diamantopoulos; Alexandre Voskuyl; Elisabeth Brouwer; Thomas Daikeler; Christoph T Berger; Eamonn S Molloy; Lorraine O'Neill; Daniel Blockmans; Benedicte A Lie; Paul Mclaren; Timothy J Vyse; Cisca Wijmenga; Yannick Allanore; Bobby P C Koeleman; Jennifer H Barrett; María C Cid; Carlo Salvarani; Peter A Merkel; Ann W Morgan; Miguel A González-Gay; Javier Martín
Journal:  Am J Hum Genet       Date:  2016-12-29       Impact factor: 11.025

7.  Editorial: Vascular Inflammation in Systemic Autoimmunity.

Authors:  Giuseppe A Ramirez; Cornelia Weyand; Augusto Vaglio; Angelo A Manfredi
Journal:  Front Immunol       Date:  2016-11-21       Impact factor: 7.561

8.  A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis.

Authors:  Raquel López-Mejías; F David Carmona; Santos Castañeda; Fernanda Genre; Sara Remuzgo-Martínez; Belén Sevilla-Perez; Norberto Ortego-Centeno; Javier Llorca; Begoña Ubilla; Verónica Mijares; Trinitario Pina; José A Miranda-Filloy; Antonio Navas Parejo; Diego de Argila; Maximiliano Aragües; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Aguirregoikoa; David Jayne; Ricardo Blanco; Javier Martín; Miguel A González-Gay
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

9.  Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.

Authors:  Lourdes Ortiz-Fernández; Francisco David Carmona; Raquel López-Mejías; Maria Francisca González-Escribano; Paul A Lyons; Ann W Morgan; Amr H Sawalha; Peter A Merkel; Kenneth G C Smith; Miguel A González-Gay; Javier Martín
Journal:  Ann Rheum Dis       Date:  2018-01-27       Impact factor: 19.103

10.  Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.

Authors:  Lourdes Ortiz-Fernández; Francisco-David Carmona; Marco-Antonio Montes-Cano; José-Raúl García-Lozano; Marta Conde-Jaldón; Norberto Ortego-Centeno; María Jesús Castillo; Gerard Espinosa; Genaro Graña-Gil; Juan Sánchez-Bursón; María Rosa Juliá; Roser Solans; Ricardo Blanco; Ana-Celia Barnosi-Marín; Ricardo Gómez de la Torre; Patricia Fanlo; Mónica Rodríguez-Carballeira; Luis Rodríguez-Rodríguez; Teresa Camps; Santos Castañeda; Juan-Jose Alegre-Sancho; Javier Martín; María Francisca González-Escribano
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.